Our research focuses on the development and clinical translation of novel quantitative Magnetic Resonance Imaging (MRI) technology, to improve the understanding, diagnosis and treatment of diseases. 

​

Clinical decisions currently rely heavily on invasive procedures, such as biopsies and surgical implants. There is a pressing clinical need to develop non-invasive, low-risk, time and cost efficient methods for improved diagnosis and treatment management. Our goal is to address this clinical need by developing an efficient MR imaging acquisition and post-processing framework to provide non-invasive, fast and comprehensive information for clinical decision support.

​

Ongoing work focuses on:

• Magnetic Resonance Fingerprinting (MRF). MRF is a novel quantitative MR imaging technique developed in our lab which permits non-invasive quantification of multiple tissue properties within clinically feasible time.

• Multi-parametric MR acquisition, reconstruction, signal modeling and post-processing.

• Clinical translation of MR Fingerprinting in early detection and characterization of neurological diseases such as epilepsy, brain tumors, and multiple sclerosis.